Asia Pacific Homeopathy Market Forecast to 2030 - Regional Analysis - by Source (Plants, Animals, and Minerals), Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, and Others), Application (Analgesic and Antipyretic, Respiratory, Neurology, Immunology, Gastroenterology, Dermatology, and Others), and Distribution Channel (Homeopathic Clinics, Retail Pharmacies, E-Retailers, and Others)
The Asia Pacific homeopathy market was valued at US$ 1,416.80 million in 2022 and is expected to reach US$ 4,443.39 million by 2030; it is estimated to grow at a CAGR of 15.4% from 2022 to 2030.
Safety Associated with Homeopathic Products fuel the Asia Pacific Homeopathy MarketHomeopathic medicines are widely considered safe as they are prescribed after special preparation processes. These involve the repeated steps of dilution and succussion of shaking at each dilution. Common potencies used are “30C,” diluted 1:100 30-times, and “200C,” diluted 1:100 20,000-times. Thus, such highly diluted medicines are prescribed by skilled professionals, which are deemed safe and are not likely to cause severe side effects. On December 6, 2022, FDA issued a final guidance, Homeopathic Drug Products, that describes the agency’s approach to prioritizing regulatory actions for homeopathic products posing the greatest risk to patients. The FDA is prioritizing specific categories of drugs, such as those intended for populations at greater risk for adverse reactions.
Asia Pacific Homeopathy Market OverviewThe homeopathy market in Asia Pacific is segmented into Japan, India, Australia, Malaysia, New Zealand, and the Rest of Asia Pacific. Rising demand for alternative medicine is driving the growth of the market. The increasing prevalence of lifestyle diseases such as heart disease, stroke, obesity, and type 2 diabetes are further boosting the market growth in the region.
Asia Pacific Homeopathy Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Homeopathy Market SegmentationThe Asia Pacific homeopathy market is segmented based on source, type, application, distribution channel, and country. Based on sources, the Asia Pacific homeopathy market is segmented into plants, animals, and minerals. The plants segment held the largest market share in 2022.
Based on type, the Asia Pacific homeopathy market is segmented into dilutions, tinctures, biochemics, ointments, tablets, and others. The dilutions segment held the largest market share in 2022.
Based on application, the Asia Pacific homeopathy market is segmented into analgesic and antipyretic, respiratory, neurology, immunology, gastroenterology, dermatology, and others. The immunology segment held the largest market share in 2022.
Based on distribution channel, the Asia Pacific homeopathy market is segmented into homeopathic clinics, retail pharmacies, e-retailers, and others. The homeopathic clinics segment held the largest market share in 2022.
Based on country, the Asia Pacific homeopathy market is segmented into Australia, Malaysia, India, Japan, New Zealand, and the Rest of Asia Pacific. India dominated the Asia Pacific homeopathy market share in 2022.
Fourrts; Boiron; Biologische Heilmittel Heel GmbH; DHU-Arzneimittel GmbH & Co. KG; Allen Healthcare Co., Ltd; and Dr Reckeweg & Co GmbH are some of the leading players operating in the Asia Pacific homeopathy market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific homeopathy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific homeopathy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific homeopathy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution